Skip to main content
. 2021 Oct 21;12:550. doi: 10.1186/s13287-021-02617-x

Fig. 7.

Fig. 7

Cell cycle analysis following the inhibition of SCD1 activity during endoderm differentiation. The induced pluripotent stem cells (iPSCs) were treated with SCD1 inhibitor (SCDinhib) alone at Days 0, 1, or 2 (0, 1, and 2) of differentiation or in combination with oleic acid (OA) at Day 0. Undifferentiated cells (Undiff) and cells treated with DMSO (< 0.05%, Mock) were served as background controls. A Representative flow cytometers of cells. B Quantification of flow cytometry analysis. *p < 0.05, **p < 0.01 versus mock, #p < 0.05, # #p < 0.01 versus the same Day in SCDinhib